Treatment of the following mild to moderate infections: acute bacterial exacerbations of chronic bronchitis(ABECB), secondary bacterial infections of acute bronchitis, pharyngitis, tonsillitis, and uncomplicated skin and skin structure infections (SSSI) caused by susceptible strains of microorganisms.
Administration/Dosage
Taking 1 tablet, 2 times a day.
Active Ingredient/Content
Cefaclor 375mg(potency)
Efficacy/Indication
Treatment of the following mild to moderate infections: acute bacterial exacerbations of chronic bronchitis(ABECB), secondary bacterial infections of acute bronchitis, pharyngitis, tonsillitis, and uncomplicated skin and skin structure infections (SSSI) caused by susceptible strains of microorganisms.